ELUTIA INC. — Director's Dealing 2023

Mar 27, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AZIYO BIOLOGICS, INC. (AZYO)
CIK: 0001708527
Period of Report: 2023-03-23

Reporting Person: Birchview Capital, LP (10% Owner)
Reporting Person: Birchview Fund LLC (10% Owner)
Reporting Person: Strobeck Matthew (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-03-23	Class A Common Stock	P	100000	$1.4910	Acquired	1615184	Indirect
2023-03-23	Class A Common Stock	P	10000	$1.4910	Acquired	1625184	Indirect
2023-03-24	Class A Common Stock	P	18000	$1.3539	Acquired	1643184	Indirect
2023-03-24	Class A Common Stock	P	2000	$1.3539	Acquired	1645184	Indirect
2023-03-27	Class A Common Stock	P	10000	$1.5870	Acquired	1655184	Indirect

Footnotes

F1: Matthew Strobeck is the Managing Member of Birchview Capital GP, LLC, who is the General Partner of Birchview Capital, LP. Matthew Strobeck is the Managing Member of Birchview Partners LLC, who is the Manager of Birchview Fund, LLC ("the Fund"). Birchview Capital, LP is the investment manager of the Fund.

F2: The Fund acquired the shares as specified in Table I. As investment manager of the Fund, Birchview Capital, LP possesses the power to vote and dispose or direct the disposition of the shares acquired by the Fund.

F3: As specified in Table I, Birchview Capital, LP advises the acquired shares in a separately managed account ("SMA").

F4: As specified in Table I, Birchview Capital, LP advises the acquired shares in a different SMA other than the one noted above.